These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38913573)

  • 1. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
    Maddali MV; Moore AR; Sinha P; Newton CA; Kim JS; Adegunsoye A; Ma SF; Strek ME; Chen CH; Linderholm AL; Zemans RL; Moore BB; Wolters PJ; Martinez FJ; Rogers AJ; Raj R; Noth I; Oldham JM
    Am J Respir Crit Care Med; 2024 Jun; ():. PubMed ID: 38913573
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
    Adegunsoye A; Alqalyoobi S; Linderholm A; Bowman WS; Lee CT; Pugashetti JV; Sarma N; Ma SF; Haczku A; Sperling A; Strek ME; Noth I; Oldham JM
    Chest; 2020 Oct; 158(4):1526-1534. PubMed ID: 32450241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
    Ruan P; Todd JL; Zhao H; Liu Y; Vinisko R; Soellner JF; Schmid R; Kaner RJ; Luckhardt TR; Neely ML; Noth I; Porteous M; Raj R; Safdar Z; Strek ME; Hesslinger C; Palmer SM; Leonard TB; Salisbury ML
    Respir Res; 2023 May; 24(1):141. PubMed ID: 37344825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study.
    Scicluna BP; van Vught LA; Zwinderman AH; Wiewel MA; Davenport EE; Burnham KL; Nürnberg P; Schultz MJ; Horn J; Cremer OL; Bonten MJ; Hinds CJ; Wong HR; Knight JC; van der Poll T;
    Lancet Respir Med; 2017 Oct; 5(10):816-826. PubMed ID: 28864056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
    Oldham JM; Huang Y; Bose S; Ma SF; Kim JS; Schwab A; Ting C; Mou K; Lee CT; Adegunsoye A; Ghodrati S; Pugashetti JV; Nazemi N; Strek ME; Linderholm AL; Chen CH; Murray S; Zemans RL; Flaherty KR; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1111-1120. PubMed ID: 37847691
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
    Suzuki Y; Mori K; Aono Y; Kono M; Hasegawa H; Yokomura K; Naoi H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Suda T
    BMC Pulm Med; 2021 Jul; 21(1):221. PubMed ID: 34247593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis.
    Kraven LM; Taylor AR; Molyneaux PL; Maher TM; McDonough JE; Mura M; Yang IV; Schwartz DA; Huang Y; Noth I; Ma SF; Yeo AJ; Fahy WA; Jenkins RG; Wain LV
    Thorax; 2023 Jun; 78(6):551-558. PubMed ID: 35534152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry.
    Lee CT; Hao W; Burg CA; Best J; Kolenic GE; Strek ME
    Respir Res; 2024 Jun; 25(1):255. PubMed ID: 38907239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact.
    De Sadeleer LJ; Verleden SE; Schupp JC; McDonough JE; Goos T; Yserbyt J; Bargagli E; Rottoli P; Kaminski N; Prasse A; Wuyts WA
    Chest; 2022 Jun; 161(6):1576-1588. PubMed ID: 35063449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment.
    Noor S; Nawaz S; Chaudhuri N
    Adv Ther; 2021 Jan; 38(1):268-277. PubMed ID: 33098554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study.
    Adams CJ; Shapera S; Ryerson CJ; Assayag D; Johannson KA; Fell CD; Morisset J; Manganas H; Kolb M; Hambly N; Cox G; Khalil N; Marcoux V; Wilcox PG; To T; Sadatsafavi M; Halayko AJ; Gershon A; Garlick K; Fisher JH
    Respir Med; 2022 Jan; 191():106722. PubMed ID: 34959146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis.
    de Andrade JA; Neely ML; Hellkamp AS; Culver DA; Kim HJ; Liesching T; Lobo LJ; Ramaswamy M; Safdar Z; Bender S; Conoscenti CS; Leonard TB; Palmer SM; Snyder LD;
    Clin Ther; 2023 Apr; 45(4):306-315. PubMed ID: 36997445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort.
    Durheim MT; Bendstrup E; Carlson L; Sutinen EM; Hyldgaard C; Kalafatis D; Myllärniemi M; Sköld CM; Sjåheim T
    Respirology; 2021 Oct; 26(10):982-988. PubMed ID: 34291523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical eye on IPF: a cohort study redefining the mortality scenario.
    Tomassetti S; Ravaglia C; Piciucchi S; Ryu J; Wells A; Donati L; Dubini A; Klersy C; Luzzi V; Gori L; Rosi E; Lavorini F; Poletti V
    Front Med (Lausanne); 2023; 10():1151922. PubMed ID: 37332746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
    Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
    Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.
    Swaminathan AC; Hellkamp AS; Neely ML; Bender S; Paoletti L; White ES; Palmer SM; Whelan TPM; Dilling DF;
    Ann Am Thorac Soc; 2022 Jun; 19(6):981-990. PubMed ID: 35073248
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry.
    Behr J; Prasse A; Wirtz H; Koschel D; Pittrow D; Held M; Klotsche J; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Bahmer T; Oqueka T; Frankenberger M; Kreuter M
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32381492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
    Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
    Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
    [No Abstract]   [Full Text] [Related]  

  • 19. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.
    Mochizuka Y; Suzuki Y; Kono M; Hasegawa H; Hashimoto D; Yokomura K; Inoue Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura H; Suda T
    Respirology; 2023 Aug; 28(8):775-783. PubMed ID: 37221050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.
    Herazo-Maya JD; Sun J; Molyneaux PL; Li Q; Villalba JA; Tzouvelekis A; Lynn H; Juan-Guardela BM; Risquez C; Osorio JC; Yan X; Michel G; Aurelien N; Lindell KO; Klesen MJ; Moffatt MF; Cookson WO; Zhang Y; Garcia JGN; Noth I; Prasse A; Bar-Joseph Z; Gibson KF; Zhao H; Herzog EL; Rosas IO; Maher TM; Kaminski N
    Lancet Respir Med; 2017 Nov; 5(11):857-868. PubMed ID: 28942086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.